Spyre Therapeutics Inc. (SYRE): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 24.07.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 103,933 US Dollar | 10 | 0 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 86.841.253 | 16,81 | 7,57 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Spyre Therapeutics Inc.
Mitarbeiter 112
Handelsplatz NASDAQ
Ticker Symbol SYRE
IPO Datum 2016-04-07
Adresse Building 23, Waltham, MA, United States, 02453
Webseite https://www.spyre.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Cameron Turtle DPHIL, Ph.D. | CEO & Director |
| 2 | Mr. Scott L. Burrows | Chief Financial Officer |
| 3 | Ms. Heidy Abreu King-Jones J.D., L.L.M. | Chief Legal Officer & Corporate Secretary |
| 4 | Dr. Sheldon Sloan M.B.E., M.D. | Chief Medical Officer |
| 5 | Dr. Janet Gunzner-Toste M.B.A., Ph.D. | Senior Vice President of Operations |
| 6 | Mr. Brian Connolly | Chief Technical Officer |
| 7 | Mr. Eric McIntyre | Senior Vice President of Finance & Investor Relations |
| 8 | Mr. James Myers | Senior Vice President of Quality & Compliance |
| 9 | Dr. Justin LaFountaine Ph.D. | Senior Vice President of Corporate Development |
| 10 | Ms. Melissa Cooper | Senior Vice President of People |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 13,57% | 1,20 Mrd. USD |
| 2 | BlackRock Inc | 6,36% | 0,56 Mrd. USD |
| 3 | RTW INVESTMENTS, LLC | 4,80% | 0,43 Mrd. USD |
| 4 | Vanguard Group Inc | 4,65% | 0,41 Mrd. USD |
| 5 | Fairmount Funds Management LLC | 4,63% | 0,41 Mrd. USD |
| 6 | Perceptive Advisors LLC | 4,36% | 0,39 Mrd. USD |
| 7 | VR Adviser, LLC | 4,24% | 0,38 Mrd. USD |
| 8 | Vanguard Capital Management, LLC | 3,52% | 0,31 Mrd. USD |
| 9 | Driehaus Capital Management LLC | 3,21% | 0,29 Mrd. USD |
| 10 | State Street Corp | 3,00% | 0,27 Mrd. USD |
| 11 | Paradigm Biocapital Advisors LP | 2,25% | 0,20 Mrd. USD |
| 12 | COMMODORE CAPITAL LP | 2,20% | 0,20 Mrd. USD |
| 13 | TCG Crossover Management, LLC | 2,19% | 0,19 Mrd. USD |
| 14 | TANG CAPITAL MANAGEMENT LLC | 2,18% | 0,19 Mrd. USD |
| 15 | Wellington Management Company LLP | 2,10% | 0,19 Mrd. USD |
| 16 | Capital Research & Mgmt Co - Division 3 | 2,01% | 0,18 Mrd. USD |
| 17 | Geode Capital Management, LLC | 1,98% | 0,18 Mrd. USD |
| 18 | HHG PLC | 1,91% | 0,17 Mrd. USD |
| 19 | RA Capital Management, LLC | 1,87% | 0,17 Mrd. USD |
| 20 | T. Rowe Price Associates, Inc. | 1,84% | 0,16 Mrd. USD |